Patients with advanced nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) can be safely and effectively treated with R-CHOP*, according to a retrospective US study. Co-author Dr Chan Cheah, now at Sir Charles Gairdner Hospital in WA, told the limbic the rarity of the disease meant prospective studies were difficult. Yet it was important to try and ...
Rare lymphoma responds to R-CHOP
By Mardi Chapman
31 May 2017